Professur für Translationale Immunforschung bei chronisch entzündlichen Darmerkrankungen (Heisenberg-Professur)

Functional molecular network analysis enables prediction of response to vedolizumab therapy in anti-TNF refractory IBD patients (2020) Breidert M, Eftekhari P, Louis F, Rotoiu C, Rath T, Neurath M, Atreya R Journal article Successful Therapy of Crohn's Disease-Associated Pulmonary Necrobiotic Nodules on Ustekinumab Therapy (2020) Ganzleben I, Hirschmann S, Köhler J, Fuchs F, Rieker R, Baer E, Klenske E, et al. Journal article The TLR9 agonist cobitolimod induces IL10 producing wound healing macrophages and regulatory T cells in ulcerative colitis (2020) Schmitt H, Ulmschneider J, Billmeier U, Scarozza P, Sonnewald S, Reid S, Atreya I, et al. Journal article, Original article Recurrent Ileal Invagination in Crohn's Disease (2020) Görtz R, Atreya R, Neurath M Journal article, Editorial Extent of Mucosal Inflammation in Ulcerative Colitis Influences the Clinical Remission Induced by Vedolizumab (2020) Scarozza P, Marafini I, Laudisi F, Troncone E, Schmitt H, Lenti MV, Costa S, et al. Journal article Molecular imaging in inflammatory bowel disease (2020) Rath T, Neurath M, Atreya R Authored book Successful cyclosporin and ustekinumab combination therapy in a patient with severe steroid-refractory ulcerative colitis (2020) Ganzleben I, Geppert CI, Osaba L, Hirschmann S, Nägel A, Glück C, Hoffman A, et al. Journal article Thumb sucking or nail biting in childhood and adolescence is associated with an increased risk of Crohn’s disease: results from a large case–control study (2020) Teich N, Mohl W, Primas C, Novacek G, Gauss A, Walldorf J, Felten G, et al. Journal article Mild COVID-19 Symptoms in an Infliximab-Treated Ulcerative Colitis Patient: Can Ongoing Anti-TNF Therapy Protect against the Viral Hyperinflammatory Response and Avoid Aggravated Outcomes? (2020) Abdullah A, Neurath M, Atreya R Journal article Effectiveness of vedolizumab therapy in a real-world setting in Germany: First results of the VEDOibd study comparing vedolizumab to the use of other biologics (2020) Bokemeyer B, Plachta-Danielzik S, Sobotzki C, Mohl W, Hoffstadt M, Krause T, Atreya R, et al. Conference contribution